Navigation Links
New Study Examines the Evolving Role of Medical Science Liaisons in the Medical Device Sector
Date:3/2/2012

CHAPEL HILL, N.C., March 2, 2012 /PRNewswire/ -- Medical Science Liaisons (MSLs) have become a key link between the medical device industry and critical stakeholders such as thought leaders that drive marketplace success. And the role of MSLs - also called medical specialists - will grow even more in the coming years as the device industry turns to them to build relationships across a diverse set of customers.

Given the expanding role of MSLs, it's critical for organizations to continually improve their MSLs group's activities and services to ensure they are creating value for diverse customer groups. To meet this need, Best Practices, LLC conducted a comprehensive research study of the structure, management and services that are hallmarks of successful MSL groups within device organizations.

"Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups within the Medical Device Industry" provides benchmarks and insights across the many services and stakeholders that MSLs are involved with as part of their growing responsibilities at device organizations.

For instance, 75 percent of research participants believe that internal managed care groups will be users of MSL support services in the next two years. Thus, MSLs will need to understand how payer groups work and how best to serve internal constituents working with them. Currently, only about 25 percent of device companies regularly support internal payer groups, according to the research.

Study topics include:

  • Key Opinion Leaders Management
  • MSL Internal Services and Activities
  • MSL Services and Payer Education and Support
  • MSL Services and Hospital/Health Care Access
  • Emerging Trends and Mitigating Risks
  • MSL Services and Physician Education
  • MSL Services and Patient Education and Advocacy Suppor
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014   DaVita ... ), one of the nation,s largest and most ... DaVita University Academy – the company,s award-winning, leadership ... Nearly 2,000 DaVita teammates from around the globe ... DaVita University Academy is a two-day one-of-a-kind ...
(Date:10/16/2014)... MARLBOROUGH, Mass. , Oct. 16, 2014 ... received CE Mark approval for the ACCOLADE TM ... leads, ACCOLADE pacemakers are the first to enable ... Tesla and 3.0 Tesla systems. In addition, the Boston ... MRI options, allowing higher energy scan sequences, and featuring ...
(Date:10/16/2014)... 2014 The Parenteral Drug Association ... application of single-use, or disposable, systems in ... products with the publication of Technical ... Single-Use Systems in Pharmaceutical Manufacturing. ... systems (SUS) or single-use equipment, has the ...
Breaking Medicine Technology:DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging 2Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging 3Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging 4Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging 5PDA Offers Help in Applying Single-Use Systems to Bio/Pharma Operations 2
... 18, 2011 The U.S. Food and Drug Administration ... treat patients with acute lymphoblastic leukemia (ALL), who have ... derived asparaginase and pegaspargase chemotherapy drugs used to treat ... Acute lymphoblastic leukemia is a type of ...
... and OXFORD, England, Nov. 18, 2011   EUSA Pharma, a ... supportive care and critical care, today announced that ... approved its orphan drug ERWINAZE™ (asparaginase Erwinia ... leukemia (ALL) in patients with hypersensitivity to ...
Cached Medicine Technology:FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE™ for Treatment of Acute Lymphoblastic Leukemia 2EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE™ for Treatment of Acute Lymphoblastic Leukemia 3EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE™ for Treatment of Acute Lymphoblastic Leukemia 4
(Date:10/19/2014)... New York, NY (PRWEB) October 19, 2014 ... ( http://www.injurybeacon.com/granuflo-dialysis/lawsuit/ ) is continuing to move forward ... claims have now been filed over the dialysis ... Case List updated on October 15th shows 2,127 ... a federal litigation underway in the U.S. District ...
(Date:10/19/2014)... October 19, 2014 One major trend ... proton therapy despite the high-cost structure leading to the ... growth. , Analysts forecast the Global Proton Therapy ... percent over the period 2013-2018. According to the report, ... the technological advances in medical diagnostics and therapeutics. The ...
(Date:10/19/2014)... When patients and their loved ones walk ... the corner to face the Hummingbird Gift Shop, they see ... sell there. There’s unique home décor. Cooking supplies. Handbags. Nautical ... is the importance this small gift shop has on the ... Neck community of the future. , Thanks to a ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 According to ... (NINDS) the vast majority of adults (up to ... point in their lives, spending at least $50 billion ... pain includes; spinal instability, stenosis, spondylolisthesis, and symptomatic degenerative ... by wear and tear associated with the aging process, ...
(Date:10/18/2014)... Dwight D. Im, M.D., FACOG, ... and The National Institute of Robotic Surgery at ... the world to successfully perform a minimally-invasive hysterectomy ... Needle Driver, developed by Intuitive Surgical, Inc. (ISRG). ... Food and Drug Administration (FDA) clearance for use ...
Breaking Medicine News(10 mins):Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 3Health News:More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports 4Health News:Proton Therapy Market to Grow at 9.50% CAGR to 2018 Forecasts a New Research Report at Sandlerresearch.org 2Health News:Proton Therapy Market to Grow at 9.50% CAGR to 2018 Forecasts a New Research Report at Sandlerresearch.org 3Health News:Proton Therapy Market to Grow at 9.50% CAGR to 2018 Forecasts a New Research Report at Sandlerresearch.org 4Health News:Riverside Tappahannock Hospital Capital Campaign Gets Boost From Community Through Gift Shop 2Health News:Riverside Tappahannock Hospital Capital Campaign Gets Boost From Community Through Gift Shop 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 2Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 4Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 5Health News:National Recognized Gynecologic Oncologist Dr. Dwight Im World's First to Perform Surgery Using New FDA Cleared Single Site Wristed Needle Driver Technology 2Health News:National Recognized Gynecologic Oncologist Dr. Dwight Im World's First to Perform Surgery Using New FDA Cleared Single Site Wristed Needle Driver Technology 3
... in US are not getting ample amounts of a nutrient ... development.// ,A new study sponsored by the National ... the top universities in America has suggested that the women ... is required to promote normal fetal brain development. ...
... deleterious effect on young, developing brains, according to researchers ... linked to lower IQ scores later in life. // ... diabetes, high cholesterol and hypertension is a well documented ... genetics at the University of Florida said, 'We're postulating ...
... after they received blood transfusion thought to be contaminated ... been// infected in the last few months in various ... died were all younger than two years old," a ... suspected donors who are thought to have HIV.HIV/AIDS infection ...
... the University of Virginia Health System have found that ... drive better when they took// OROS methylphenidate (OROS MPH), ... (se-AMPH ER). The findings, which reinforce the use of ... ADHD, will appear in the Sept. issue of Pediatrics. ...
... has been released by Australian obesity experts that show gastric ... conference on obesity in Sydney there were three studies which ... in mortality rates in obese people who had the surgery. ... upper part of the stomach for the procedure to restrict ...
... in children that can often be disabling and one ... from school could mainly be due to their genetic// ... Medicine (Department of Psychological Medicine), in a genetic study ... usually occur together, they are of different genetic and ...
Cached Medicine News:Health News:Americans Deficient In Dietary Intake Of Choline Needed for Fetal Brain Development 2Health News:Americans Deficient In Dietary Intake Of Choline Needed for Fetal Brain Development 3Health News:Obesity Takes its Toll on IQ of Toddlers 2Health News:Not All ADHD Drugs Are Equal 2
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
... The InstaCheck® multi-drug test device ... and easily. Negative results can ... as 3 minutes; positive results ... simple, one-time urine sample application ...
Medicine Products: